ONWARD MEDICAL Aktie

 

EINDHOVEN, the Netherlands, June 17, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD and US OTCQX: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injury (SCI) and other movement disabilities, today announces its Q1 2025 business update and year-to-date highlights:...

THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014)...

EINDHOVEN, the Netherlands, June 11, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD and US OTCQX: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function and independence in people with spinal cord injury and other movement disabilities, today announces that it will host a webcast to discuss its Q1 2025 business update and year-to-date highlights....

EINDHOVEN, the Netherlands, May 21, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD and US OTCQX: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function and independence in people with spinal cord injury (SCI) and other movement disabilities, today announces that two additional individuals with spinal cord injury have received ONWARD's investigational ARC-BCI® Therapy, bringing the total number of successful implants to five....

ONWARD Medical Convocation of the 2025 Annual General Meeting of Shareholders and Proposed Resolutions...

ONWARD Medical Announces Release of 2024 Annual Report...

ONWARD Medical Establishes US ADR Program and Begins Trading on OTCQX Best Market...

NEW YORK, April 23, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced ONWARD Medical N.V. (Euronext Brussels: ONWD; OTCQX: ONWRF, ONWRY), a medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (SCI) and other movement disabilities now trades on the OTCQX market....

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

ONWARD Medical Reports Full Year 2024 Financial and Operating Results and Shares 2025 Year-to-Date Highlights...

ONWARD Medical Announces First-in-Human Use of ARC-IM Lumbar Lead Designed to Restore Standing, Stepping, and Lower Limb Mobility...

ONWARD Medical Schedules Reporting of Full Year 2024 Financial Results and Business Update Webcast...

ONWARD Medical to Advance Parkinson's Disease Pipeline with Support from The Michael J. Fox Foundation and US Department of Defense...

ONWARD Medical Announces Publication of One-Year Study Showing Benefit of Sustained Access to ARC-EX Therapy...

ONWARD Medical's ARC-EX System Now Available on US Veterans Affairs Online Procurement Platforms...

ONWARD Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference...

ONWARD Medical Announces First Commercial Sales of ARC-EX System...

ONWARD Medical Receives FDA De Novo Classification and US Market Authorization for World's First Non-Invasive Spinal Cord Stimulation System...

ONWARD Medical Ranks in Top 15 Percent Globally for Corporate Sustainability...

ONWARD Medical Provides Q3 2024 Update and Year-to-Date Highlights...